» Articles » PMID: 38451613

Higher Arterial Stiffness Predicts Chronic Kidney Disease in Adults: The ELSA-Brasil Cohort Study

Overview
Date 2024 Mar 7
PMID 38451613
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Arterial stiffening can directly affect the kidneys, which are passively perfused by a high flow. However, whether the relation between arterial stiffness and renal function depends on diabetes and hypertension conditions, is a matter of debate.

Objective: To investigate the relationship between arterial stiffening by carotid-to-femoral pulse wave velocity (cfPWV) and chronic kidney disease (CKD) incidence in individuals and verify whether this association is present in individuals without hypertension and diabetes.

Methods: A longitudinal study of 11,647 participants of the ELSA-Brasil followed up for four years (2008/10-2012/14). Baseline cfPWV was grouped per quartile, according to sex-specific cut-offs. Presence of CKD was ascertained by glomerular filtration rate (eGFR-CKD-EPI) < 60 ml/min/1.73 m2 and/or albumin-to-creatinine ratio ≥ 30 mg/g. Logistic regression models were run for the whole cohort and a subsample free from hypertension and diabetes at baseline, after adjustment for age, sex, race, schooling, smoking, cholesterol/HDL ratio, body mass index, diabetes, use of antihypertensive, systolic blood pressure, heart rate, and cardiovascular disease. Statistical significance was set at 5%.

Results: The chance of CKD was 42% (CI 95%: 1.05;1.92) greater among individuals in the upper quartile of cfPWV. Among normotensive, non-diabetic participants, individuals in the 2nd, 3rd, and 4th quartiles of cfPWV presented greater chances of developing CKD, as compared to those in the lower quartile, and the magnitude of this association was the greatest for those in the upper quartile (OR: 1.81 CI 95%: 1.14;2.86).

Conclusion: Higher cfPWV increased the chances of CKD and suggests that this effect is even greater in individuals without diabetes and hypertension.

Citing Articles

Arterial Stiffness and Chronic Kidney Disease Prediction.

Inuzuka S, Barroso W Arq Bras Cardiol. 2024; 120(12):e20230779.

PMID: 38451616 PMC: 11021035. DOI: 10.36660/abc.20230779.

References
1.
Dekkers I, de Mutsert R, Rabelink T, Jukema J, de Roos A, Rosendaal F . Associations between normal range albuminuria, renal function and cardiovascular function in a population-based imaging study. Atherosclerosis. 2018; 272:94-100. DOI: 10.1016/j.atherosclerosis.2018.03.029. View

2.
Mill J, Pinto K, Griep R, Goulart A, Foppa M, Lotufo P . [Medical assessments and measurements in ELSA-Brasil]. Rev Saude Publica. 2013; 47 Suppl 2:54-62. DOI: 10.1590/s0034-8910.2013047003851. View

3.
Ford M, Tomlinson L, Chapman T, Rajkumar C, Holt S . Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension. 2010; 55(5):1110-5. DOI: 10.1161/HYPERTENSIONAHA.109.143024. View

4.
Lu Y, Kiechl S, Wang J, Xu Q, Kiechl S, Pechlaner R . Global distributions of age- and sex-related arterial stiffness: systematic review and meta-analysis of 167 studies with 509,743 participants. EBioMedicine. 2023; 92:104619. PMC: 10327869. DOI: 10.1016/j.ebiom.2023.104619. View

5.
Luyckx V, Tuttle K, Garcia-Garcia G, Gharbi M, Heerspink H, Johnson D . Reducing major risk factors for chronic kidney disease. Kidney Int Suppl (2011). 2019; 7(2):71-87. PMC: 6341126. DOI: 10.1016/j.kisu.2017.07.003. View